GlaxoSmithKline (GSK)

GSK Puts Lucozade and Ribena Drink Brands up for Sale

UK Blocks Shell Paying Iran Oil Debt in Food, Medicin

Astellas, GSK Vie to Make 'High Altitude' Anaemia Pill

UK Watchdog Accuses GSK Over 'Pay-for-delay' Drug Deals

GSK Plans $1 Million Prize to Jump-start "Electroceuticals"

Optimer Shares Rise After Report Names Glaxo, Cubist as Potential Buyers

Antibiotics Crisis Prompts Rethink on Risks, Rewards

GlaxoSmithKline Boss Says New Drugs Can Be Cheaper

GlaxoSmithKline Unit Joins Patent Pool for AIDS Drugs

Switzerland's Roche Pledges to Open Up Access to Drug Data

Drugmakers Eye Africa's Middle Classes as Next Growth Market

GSK Vaccine Ingredient Scrutinized for Narcolepsy Clues

Buyers Eye Multibillion Deal for Brazilian Drugmaker

GlaxoSmithKline Promises Growth This Year After 2012 Shortfall

GSK Spends $900 Million to Lift Stake in India Consumer Arm

Revived Search for a TB Vaccine May Be About to Pay Off

Topics • Technology

The Chemicals and Pharmaceuticals Industry in Great Britain

Evidence Grows for Narcolepsy Link to GlaxoSmithKline's Swine Flu Shot

U.S. Government Investment Gives Flu Vaccines a Shot in the Arm

Drug Industry Bets on New Blockbusters in 2013

China to Cut Prices of More than 400 Drugs from February

Entering the Age of the $1 Million Medicine

Number of New Drugs Picks Up in Europe and U.S.

Drug Industry Treading Water on R&D Productivity

GSK and J&J Lead Rivals in Drug Access for Poor

Merck KGaA to Resist Lure of Potential Proceeds from OTC Sale

GSK to Raise India Unit Stake in $940 Million Deal

EU Doctors Turn to Last-Ditch Antibiotics as Resistance Grows

Drugmakers Offer to Cap Greece's Medicines Bill

GlaxoSmithKline Wins Top Prize at IChemE Awards

Vertex Posts Q3 Loss as Hepatitis Drug Sales Plunge

GSK Raises Bet on AIDS Drug with New Shionogi Deal

Canada's Top Court Rules for Glaxo in Tax Case

GlaxoSmithKline to Reveal More Drug Secrets

The European Pharmaceuticals Economy at Halftime 2012

76 more articles

Top-Feature

Agilent Technologies Inc.

Comprehensive Insights into Antibody–Drug Conjugates (ADC) for Precision Cancer Therapy

Aenova Holding GmbH

Mastering Modified Release: The Pellet-Based Approach

Operationalizing AI in Polymer Development: How Syensqo Is Scaling Impact with the Citrine Platform

Capillary Electrophoresis in Biotherapeutic Development: Platform Methods, Fragment Workflows, and ADC Characterization

Evonik Industries AG

Safer, Scalable Pharmaceutical Manufacturing with Flow Chemistry

Global Impact Coalition (GIC)

Siemens Joins the Global Impact Coalition

CHEManager International c/o Wiley-VCH GmbH

Upcoming Virtual Events

Article

The State of the US Specialty Chemicals Industry

Reshaping Specialty Chemicals Manufacturing

The State of the US Specialty Chemicals Industry

SOCMA's Jenn Klein examines how specialty chemical manufacturers — the invisible backbone behind pharmaceuticals, electronics, agriculture, and energy — are navigating supply chain shifts, policy uncertainty, and constant change while remaining resilient, disciplined, and focused on execution.

Sanofi S.A.

GlaxoSmithKline (GSK) plc

EDB Singapore

Microinnova Engineering GmbH

Novo Nordisk A/S

Cincinnati USA Reg. Chamber

Oracle Germany

Thermo Fisher Scientific

EvaluatePharma

Thomson Reuters

Society of Chemical Industry (SCI)

Chemical Market Reporter

ISPE D/A/CH e.V.

Novartis International AG